SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-176184
Filing Date
2023-06-27
Accepted
2023-06-27 16:30:52
Documents
12
Period of Report
2023-06-21
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d519602d8k.htm   iXBRL 8-K 22449
  Complete submission text file 0001193125-23-176184.txt   147146

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20230621.xsd EX-101.SCH 2500
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20230621_lab.xml EX-101.LAB 18731
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20230621_pre.xml EX-101.PRE 11677
6 EXTRACTED XBRL INSTANCE DOCUMENT d519602d8k_htm.xml XML 3616
Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 231047729
SIC: 2836 Biological Products, (No Diagnostic Substances)